XL147 analogue
Catalog No. A10995
XL147 analogue是一种有效的,选择性的,口服可生物利用的I类磷脂酰肌醇3激酶(PI3K)小分子抑制剂,作用于PI3Kα/δ/γ,对PI3Kβ作用效果稍弱。具有潜在的抗肿瘤活性。
- Yushi Hayashida, .et al. Invention of a novel photodynamic therapy for tumors using a photosensitizing PI3K inhibitor, Int J Cancer, 2016, Aug 1;139(3):700-11 PMID: 26989815
Catalog Num | A10995 |
---|---|
M. Wt | 448.5 |
Formula | C21H16N6O2S2 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 956958-53-5 |
Synonyms | XL-147, SAR245408 |
SMILES | CC1=CC=C(C=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=CC5=NSN=C5C=C4 |
XL147 analogue是一种有效的,选择性的,口服可生物利用的I类磷脂酰肌醇3激酶(PI3K)小分子抑制剂,作用于PI3Kα/δ/γ,对PI3Kβ作用效果稍弱。具有潜在的抗肿瘤活性。
Targets
Target | Value |
---|---|
PI3Kγ | IC50: 23nM |
PI3Kδ | IC50: 36nM |
PI3Kα | IC50: 39nM |
PI3Kβ | IC50: 383nM |
DNA-PK | IC50: 4.75μM |
Vps34 | IC50: 6.975μM |
MEK | IC50: >10μM |
B-Raf/C-Raf | IC50: >10μM |
mTOR | IC50: >15μM |
In vitro (25°C) | DMSO | 3 mg/mL (6.68 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 30% PEG400+0.5% Tween80+5% propylene glycol | 14 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.3 mL | 111.48 mL | 222.97 mL |
0.5 mM | 4.46 mL | 22.3 mL | 44.59 mL |
1 mM | 2.23 mL | 11.15 mL | 22.3 mL |
5 mM | 0.45 mL | 2.23 mL | 4.46 mL |
*The above data is based on the productmolecular weight 448.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.